BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3608781)

  • 1. [Effect of single-dose verapamil on ventricular wall movement in hypertrophic cardiomyopathy].
    Wang AA; Gu FS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Feb; 15(1):25-6. PubMed ID: 3608781
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relaxation and regional myocardial stiffness in obstructive hypertrophic cardiopathy patients: effect of verapamil].
    Bonandi L; Hess OM; Grimm J; Krayenbühl HP
    G Ital Cardiol; 1984 Feb; 14(2):77-84. PubMed ID: 6538857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy].
    Dabrowski M; Górecka B; Witkowski A; Jodkowski J; Woroszylska M; Ruzyłło W
    Kardiol Pol; 1986; 29(5-6):345-55. PubMed ID: 3784250
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of verapamil on the left ventricular function in hypertrophic obstructive cardiomyopathy].
    Guo HS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):13-6. PubMed ID: 6540163
    [No Abstract]   [Full Text] [Related]  

  • 5. [Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cas Lek Cesk; 1987 Mar; 126(11):330-4. PubMed ID: 3829106
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
    Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
    Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of verapamil on systolic time intervals and relaxation time in hypertrophic cardiomyopathy (author's transl)].
    Hirose K; Shimada T; Matsumura T; Iwata M; Yasunaga K; Hori K; Matsusaka J
    J Cardiogr; 1981 Dec; 11(4):1223-32. PubMed ID: 7201494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)].
    Schmid P; Pavek P; Klein W
    Z Kardiol; 1979 Feb; 68(2):89-92. PubMed ID: 570768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of long-term verapamil treatment of patients with hypertrophic cardiomyopathy].
    Dabrowski M; Michalak E; Maurin A; Rydlewska-Sadowska W; Ruzyłło W
    Kardiol Pol; 1989; 32 Suppl 2():6-16. PubMed ID: 2634154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of verapamil in the treatment of hypertrophic cardiomyopathy.
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cor Vasa; 1986; 28(6):404-12. PubMed ID: 3829686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil: an effective calcium blocking agent for pediatric patients.
    Porter CJ; Garson A; Gillette PC
    Pediatrics; 1983 May; 71(5):748-55. PubMed ID: 6340050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
    Hopf R; Thomas J; Klepzig H; Kaltenbach M
    Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Doppler evaluation of left ventricular diastolic filling after intravenous injection of verapamil in patients with hypertrophic cardiomyopathy].
    Jin L; Zhu WL; Mu JL
    Zhonghua Nei Ke Za Zhi; 1988 Jul; 27(7):412-4, 454. PubMed ID: 3064997
    [No Abstract]   [Full Text] [Related]  

  • 14. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy].
    Zhao ZL
    Zhonghua Nei Ke Za Zhi; 1983 Jul; 22(7):439-41. PubMed ID: 6685611
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of verapamil on the left ventricular diastolic function and diastolic asynchrony in patients with hypertrophic cardiomyopathy].
    Emoto R; Yokota Y; Miki T; Usuki S; Miki T; Nomura H; Takeuchi Y; Nakatani M; Fukuzaki H
    J Cardiol; 1991; 21(1):87-96. PubMed ID: 1817184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of verapamil on left ventricular diastolic function at rest and during isometric exercise in patients with hypertrophic cardiomyopathy.
    Bryhn M; Eskilsson J
    Clin Cardiol; 1987 Jan; 10(1):31-6. PubMed ID: 3815911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action of verapamil in a single oral dose in arterial hypertension. Evaluation by echocardiography and phonomechanocardiography].
    Ortiz J; Barreto AC; Savioli RM; Barbato AJ; Netto MP; Monaco CA; Del Nero Júnior E; Tranchesi J; Pileggi F
    Arq Bras Cardiol; 1979 Jan; 32(1):63-70. PubMed ID: 464849
    [No Abstract]   [Full Text] [Related]  

  • 20. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.